Incannex Healthcare Limited (IXHL) vs Metagenomi, Inc. Common Stock (MGX)

A side-by-side comparison of Incannex Healthcare Limited and Metagenomi, Inc. Common Stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

IXHL

Incannex Healthcare Limited

$38M

$3.18HealthcareDelayed quote: Oct 6, 2026, 12:44 PM EDT

MGX

Metagenomi, Inc. Common Stock

$40M

$1.07HealthcareDelayed quote: Oct 6, 2026, 12:45 PM EDT

Total return — IXHL vs MGX

growth of $100 · dividends reinvested · last 3y

IXHL -96.6% (-67.6%/yr)MGX -89.9% (-53.4%/yr)MGX compounded faster over this window

IXHL MGX

IXHL vs MGX: by the numbers

•MGX is the larger company ($40M vs $38M market cap).
•Both run net losses; IXHL's is the smaller (0.00% vs -689.20% net margin).

Metrics side by side

Valuation

Metric	IXHL	MGX
P/S ratio	N/A	2.96
P/B ratio	0.56	0.36

Profitability

Metric	IXHL	MGX
Gross margin	0.00%	74.29%
Operating margin	0.00%	-380.85%
Net margin	0.00%	-689.20%
ROE	-28.65%	-83.03%
ROIC	-32.18%	-66.03%

Go deeper

Full IXHL analysis Full MGX analysis Interactive comparison tool

Dig into the metrics

Incannex Healthcare ROE Metagenomi, Inc. Common Stock ROE Incannex Healthcare operating margin Metagenomi, Inc. Common Stock operating margin Incannex Healthcare revenue growth Metagenomi, Inc. Common Stock revenue growth Incannex Healthcare free cash flow Metagenomi, Inc. Common Stock free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.